Citeline Podcasts

Bayer AG’s Phase III failure

Bayer AG’s Phase III failure

US group seeks Japan changes

Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls

Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences

EY's Arda Ural on IPOs, Financial Markets and Tarrifs

Datamonitor Healthcare Podcast: ESMO 2025

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Nov. 10, 2025

Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center

Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Nov. 4, 2025

Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform

Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine

Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?

국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 27, 2025

Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape

Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

Innovating Autoimmune Treatment with In Vivo CAR-T

How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 20, 2025

Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy

Adalvo: Exploring European B2B Pharma’s Next Steps

Lupus Clinical Development Enters a New Era of Innovation

Essential Pharma – Following A Patient First Philosophy

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 14, 2025

Exploring The Intersection Of Skincare, AI, And Business With Sampo Parkkinen

Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases

Defining the Next Era of Disruption

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao

Scrip's Five Must-Know Things - Oct. 6, 2025

Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025

Scrip's Five Must-Know Things - Sept. 30, 2025

The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy

3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025

Scrip's Five Must-Know Things - September 22, 2025

ICROM on Innovation in HPAPI & Crystallization

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025

Scrip's Five Must-Know Things - September 16, 2025

The 2022 Pharma R&D Review Audio Book

Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report